Showing results (161-170 of 537) with videos related to

Sort By:
Pageof 54
Journal of Biological Regulators and Homeostatic Agents|April 1, 1987
Recombinant interferon alpha-2 modulates hairy cell phenotype "in vitro"A Fattorossi, A Dolei, J G Pizzolo, et al.
Tumori|June 30, 1986
Unusual dermatologic toxicity of long-term therapy with hydroxyurea in chronic myelogenous leukemiaE Montefusco, G Alimena, R Gastaldi, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Pharmacological purging of syngeneic bone marrow ex vivo: effect of treatment with doxorubicin and lonidamine on normal and leukaemic cells of DBA/2 miceA Sandrelli, P De Fabritiis, A Capua, et al.
European Journal of Haematology|March 1, 1989
Intermediate-dose (25 mg/m2) intravenous melphalan for patients with multiple myeloma in relapse or refractory to standard treatmentM T Petrucci, G Avvisati, M Tribalto, et al.
Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy|April 1, 1984
2-Methyl-9-hydroxyellipticinium acetate (ellipticinium) in the treatment of lymphomas. Preliminary results of a phase II studyS Tura, F Mandelli, P Mazza, et al.
Acta Haematologica|January 1, 1977
Glucose-6-phosphate dehydrogenase VelletriF Mandelli, S Amadori, A De Laurenzi, et al.
Medical and Pediatric Oncology|January 1, 1978
Daunomycin, cytosine arabinoside and 6-thioguanine (DAT) vs vincristine, cytosine arabinoside and 6-thioguanine (VAT) in the induction treatment of acute nonlymphocyte leukemia: a randomized collaborative studyF Mandelli, E De Lipsis, F Grignani, et al.
Tumori|May 1, 1981
Involvement of the bone marrow by non-Hodgkin's lymphomas: incidence, histology and pathologic correlationsC D Baroni, L Manente, M Occhionero, et al.
Cancer Treatment Reports|August 1, 1980
Sequential combination of methotrexate and L-asparaginase in the treatment of refractory acute leukemiaS Amadori, M Tribalto, L Pacilli, et al.
Biomedicine / [Publiee Pour L'A.A.I.C.I.G.]|February 1, 1978
Immunological rebound following cessation of chemotherapy in 15 acute lymphoid leukemia patients in complete remissionG De Rossi, M Tribalto, B Monarca, et al.
Pageof 54